Zyner­ba cites 'triple­demic' for PhI­II de­lay of a cannabi­noid drug that's failed mul­ti­ple times

Zyner­ba Phar­ma­ceu­ti­cals’ cannabi­noid drug has flamed out mul­ti­ple times over the years, and the biotech’s lat­est at­tempt at prov­ing the gel’s ef­fi­ca­cy is be­ing ham­pered …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER